Do you want to read an article? Please log in or register.
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
Diabetes - GeneralType 2 DiabetesGlycemic Control